In addition to affecting the immune microenvironment of pancreatic cancer, GFPT2 has also been reported to be related to the malignant biological behavior of cancer cells in a variety of other cancers including colon cancer, breast cancer and serous ovarian cancer [18–20]. The gene discussed is GFPT2; the disease is breast carcinoma.